Marc-Arthur Loko - Publications

Affiliations: 
Université de Bordeaux, Talence, Nouvelle-Aquitaine, France 

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Tan BK, Chalouni M, Ceron DS, Cinaud A, Esterle L, Loko MA, Katlama C, Poizot-Martin I, Neau D, Chas J, Morlat P, Rosenthal E, Lacombe K, Naqvi A, Barange K, et al. Atherosclerotic Cardiovascular Events in Patients Infected With Human Immunodeficiency Virus and Hepatitis C Virus. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32686834 DOI: 10.1093/Cid/Ciaa1014  0.653
2015 Carrieri MP, Serfaty L, Vilotitch A, Winnock M, Poizot-Martin I, Loko MA, Lions C, Lascoux-Combe C, Roux P, Salmon-Ceron D, Spire B, Dabis F. Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH). Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 61: 40-8. PMID 25778750 DOI: 10.1093/Cid/Civ217  0.724
2015 Miailhes P, Gilbert C, Lacombe K, Arends JE, Puoti M, Rockstroh JK, Sogni P, Fontaine H, Rosenthal E, Winnock M, Loko MA, Wittkop L, Dabis F, Salmon D. Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1-coinfected patients. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 25650873 DOI: 10.1111/Liv.12799  0.748
2014 Marcellin F, Roux P, Loko MA, Lions C, Caumont-Prim A, Dabis F, Salmon-Ceron D, Spire B, Carrieri MP. High levels of alcohol consumption increase the risk of advanced hepatic fibrosis in HIV/hepatitis C virus-coinfected patients: a sex-based analysis using transient elastography at enrollment in the HEPAVIH ANRS CO13 cohort. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 59: 1190-2. PMID 25015913 DOI: 10.1093/Cid/Ciu525  0.669
2014 Marcellin F, Roux P, Winnock M, Lions C, Dabis F, Salmon-Ceron D, Loko MA, Spire B, Carrieri MP. Using patient-reported outcomes to improve the management of co-infection with HIV and HCV: the ANRS CO13 HEPAVIH cohort. Expert Review of Gastroenterology & Hepatology. 8: 351-8. PMID 24580042 DOI: 10.1586/17474124.2014.888949  0.727
2014 Bani-Sadr F, Loko MA, Pambrun E, Winnock M, Carrieri P, Gilbert C, Duvivier C, Bouchaud O, Gervais A, Dabis F, Salmon D. Correlates of HIV sustained viral suppression in HIV/hepatitis C virus coinfected patients: possible role of the hepatitis C virus sustained viral response. Aids (London, England). 28: 1155-60. PMID 24499953 DOI: 10.1097/Qad.0000000000000218  0.723
2013 Marcellin F, Lions C, Winnock M, Salmon D, Durant J, Spire B, Mora M, Loko MA, Dabis F, Dominguez S, Roux P, Carrieri MP. Self-reported alcohol abuse in HIV-HCV co-infected patients: A better predictor of HIV virological rebound than physician's perceptions (HEPAVIH ARNS CO13 cohort) Addiction. 108: 1250-1258. PMID 23421419 DOI: 10.1111/Add.12149  0.629
2012 Loko MA, Bani-Sadr F, Valantin MA, Lascoux-Combe C, Fontaine H, Bonnard P, Gervais A, Bouchaud O, Garipuy D, Quertainmont Y, Vittecoq D, Tehrani MS, Winnock M, Dabis F, Salmon D, et al. Antiretroviral therapy and sustained virological response to HCV therapy are associated with slower liver fibrosis progression in HIV-HCV-coinfected patients: study from the ANRS CO 13 HEPAVIH cohort. Antiviral Therapy. 17: 1335-43. PMID 23052829 DOI: 10.3851/Imp2419  0.738
2012 Carrieri MP, Sogni P, Cohen J, Loko MA, Winnock M, Spire B. Elevated coffee consumption and reduced risk of insulin resistance in HIV-HCV coinfected patients (HEPAVIH ANRS CO-13). Hepatology (Baltimore, Md.). 56: 2010. PMID 22535683 DOI: 10.1002/Hep.25813  0.626
2012 Salmon-Ceron D, Cohen J, Winnock M, Roux P, Sadr FB, Rosenthal E, Martin IP, Loko MA, Mora M, Sogni P, Spire B, Dabis F, Carrieri MP. Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France). Bmc Health Services Research. 12: 59. PMID 22409788 DOI: 10.1186/1472-6963-12-59  0.741
2012 Trimoulet P, Merchadou L, Winnock M, Loko MA, Fleury H, Salmon D, Dabis F, Neau D. Hepatitis C virus RNA quantitation in a nationwide French cohort of patients co-infected with HIV and HCV: should the same test be applied to all samples? Journal of Virological Methods. 181: 131-3. PMID 22285372 DOI: 10.1016/j.jviromet.2012.01.006  0.633
2012 Salmon D, Bani-Sadr F, Loko MA, Stitou H, Gervais A, Durant J, Rosenthal E, Quertainmont Y, Barange K, Vittecoq D, Shoai-Tehrani M, Alvarez M, Winnock M, Trinchet JC, Dabis F, et al. Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH. Journal of Hepatology. 56: 862-8. PMID 22173166 DOI: 10.1016/J.Jhep.2011.11.009  0.714
2010 Loko MA, Salmon D, Carrieri P, Winnock M, Mora M, Merchadou L, Gillet S, Pambrun E, Delaune J, Valantin MA, Poizot-Martin I, Neau D, Bonnard P, Rosenthal E, Barange K, et al. The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010. Bmc Infectious Diseases. 10: 303. PMID 20969743 DOI: 10.1186/1471-2334-10-303  0.733
2008 Loko MA, Castera L, Dabis F, Le Bail B, Winnock M, Coureau G, Bioulac-Sage P, De Ledinghen V, Neau D, Chêne G, Dupon M, Longy-Boursier M, Morlat P, Pellegrin JL, Ragnaud JM, et al. Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine Cohort American Journal of Gastroenterology. 103: 1973-1980. PMID 18796094 DOI: 10.1111/J.1572-0241.2008.01954.X  0.705
2007 Trimoulet P, Boutonnet M, Winnock M, Faure M, Loko MA, De Lédinghen V, Bernard PH, Castéra L, Foucher J, Dupon M, Ragnaud JM, Lafon ME, Couzigou P, Dabis F, Fleury H, et al. Hepatitis B virus genotypes: a retrospective survey in Southwestern France, 1999-2004. Gastroentã©Rologie Clinique Et Biologique. 31: 1088-94. PMID 18176363 DOI: 10.1016/S0399-8320(07)78341-0  0.596
2007 Neau D, Winnock M, Castéra L, Bail BL, Loko MA, Géraut L, Dupon M, Ragnaud JM, Lacoste D, Lafon ME, Bioulac-Sage P, Dabis F. Prevalence of and factors associated with hepatic steatosis in patients coinfected with hepatitis C virus and HIV: Agence Nationale pour la Recherche contre le SIDA et les hépatites virales CO3 Aquitaine Cohort. Journal of Acquired Immune Deficiency Syndromes (1999). 45: 168-73. PMID 17527092 DOI: 10.1097/Qai.0B013E318042E1Db  0.746
2005 Loko MA, Toure S, Dakoury-Dogbo N, Gabillard D, Leroy V, Anglaret X. Decreasing incidence of pregnancy by decreasing CD4 cell count in HIV-infected women in Côte d'Ivoire: a 7-year cohort study. Aids (London, England). 19: 443-5. PMID 15750400 DOI: 10.1097/01.Aids.0000161776.30815.44  0.526
Show low-probability matches.